Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
AssigneeLitron Laboratories, Ltd.
InventorsStephen D. Dertinger, Jeffrey C. Bemis, Steven M. Bryce
Life of this patent
Estimating the term…
Loading patent…
AssigneeLitron Laboratories, Ltd.
InventorsStephen D. Dertinger, Jeffrey C. Bemis, Steven M. Bryce
Estimating the term…
The present invention relates a method for assessing in vivo hematotoxicity. The method utilizes differential staining of nucleated and non-nucleated blood cells, and also differential labeling of cells with functional versus dysfunctional mitochondrial membrane potential. Quantitative analyses can be conducted on stained whole blood specimens, and is based on blood cells' fluorescent emission and light scatter properties following exposure to an excitatory light source. The ratio of certain cell populations can be readily measured. Furthermore, it is also possible to express cell population values in terms of number per unit volume. This invention can be used to evaluate the hematotoxicity of drugs, chemicals, radiation, and other exogenous agents, or the effects that a suspected protective agent may have on induced hematotoxicity. Furthermore, the matrix of measurements provided by this invention is useful in estimating radiation dose, i.e., retrospectively. Kits for practicing the invention are also disclosed.
A method for enumeration of blood cells and blood platelets to assess the degree of hematotoxicity resulting from exposure to a hazardous exogenous agent, the method comprising:
Dependencies are inferred from the claim text.